000			01548 a2200409 4500
005			20250511221216.0
264		0	_c19910726
008			199107s 0 0 eng d
022			_a0022-5347
024	7		_a10.1016/s0022-5347(17)37747-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aKim, J H
245	0	0	_aInhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution. _h[electronic resource]
260			_bThe Journal of urology _cJul 1991
300			_a171-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAntineoplastic Agents
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCell Line
650	0	4	_aDepression, Chemical
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aErbB Receptors _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aSuramin _xtherapeutic use
650	0	4	_aTransforming Growth Factor alpha _xanalysis
650	0	4	_aTumor Cells, Cultured _xdrug effects
700	1		_aSherwood, E R
700	1		_aSutkowski, D M
700	1		_aLee, C
700	1		_aKozlowski, J M
773	0		_tThe Journal of urology _gvol. 146 _gno. 1 _gp. 171-6
856	4	0	_uhttps://doi.org/10.1016/s0022-5347(17)37747-9 _zAvailable from publisher's website
999			_c2062753 _d2062753